Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-46,699
Closed -$3.1M 768
2025
Q4
$3.1M Sell
46,699
-9,690
-17% -$626K 0.07% 193
2025
Q3
$3.79M Sell
56,389
-1,311
-2% -$104K 0.08% 173
2025
Q2
$5.04M Sell
57,700
-7
-0% -$549 0.12% 143
2025
Q1
$3.94M Sell
57,707
-756
-1% -$61.7K 0.1% 154
2024
Q4
$4.55M Buy
58,463
+16,968
+41% +$1.26M 0.12% 145
2024
Q3
$2.78M Sell
41,495
-15,549
-27% -$1.28M 0.07% 196
2024
Q2
$6.47M Sell
57,044
-4,980
-8% -$630K 0.18% 117
2024
Q1
$8.6M Buy
62,024
+6,356
+11% +$799K 0.24% 94
2023
Q4
$6.91M Sell
55,668
-9,850
-15% -$1.01M 0.2% 110
2023
Q3
$6.11M Buy
65,518
+14,950
+30% +$1.69M 0.2% 106
2023
Q2
$6.5M Buy
50,568
+8,937
+21% +$1.08M 0.23% 97
2023
Q1
$4.84M Buy
41,631
+6,023
+17% +$674K 0.17% 114
2022
Q4
$4.03M Sell
35,608
-88
-0.2% -$9.66K 0.15% 123
2022
Q3
$2.88M Sell
35,696
-1,064
-3% -$90.1K 0.12% 149
2022
Q2
$2.74M Sell
36,760
-736
-2% -$67.2K 0.11% 165
2022
Q1
$4.8M Sell
37,496
-12
-0% -$1.31K 0.16% 123
2021
Q4
$5.04M Buy
37,508
+220
+0.6% +$31.6K 0.16% 121
2021
Q3
$5.1M Hold
37,288
0.17% 116
2021
Q2
$3.98M Hold
37,288
0.14% 143
2021
Q1
$3.35M Buy
+37,288
New +$3.5M 0.12% 148

Other funds holding DXCM

Bailard's DXCM Position: Q1 2026 in Review

Bailard sold out of DexCom (DXCM) in Q1 2026, closing a stake of 46,699 shares — an estimated $3.1M sold.

Bailard first reported a position in DXCM in Q1 2021 and held it in 20 quarters. The position peaked at $8.6M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Bailard reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Bailard sold 46,699 DexCom shares in Q1 2026, an estimated $3.1M.
  • Bailard first reported a position in DexCom in Q1 2021 and held it in 20 quarters.
  • Bailard's DexCom position peaked at $8.6M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Bailard's 13F filing for Q1 2026, filed 11 May 2026.